General Information of This Drug (ID: DM2P6R0)

Drug Name
Inosine pranobex   DM2P6R0
Synonyms Imunovir (TN)
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Approved [1]
Virus infection 1A24-1D9Z Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Levamisole + Inosine pranobex DCGQ05Z Levamisole Coronavirus Disease 2019 (COVID-19) [2]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 ClinicalTrials.gov (NCT04383717) Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial. U.S. National Institutes of Health.